Where AI is accelerating across health and science
A 19-month comparison separates AI supply across clinical diagnostics, drug discovery, biology, patient operations, materials, mathematics, and autonomous science.
Health and science AI is fragmenting into markets with different formation speeds
The measured health-and-science supply index changed +61.9% between Q1 2025 and May–July 2026. Autonomous scientific discovery accelerated fastest (+345.5%), while clinical diagnostics & imaging remained the largest observed body of work. The category is not moving as a single market.
Market snapshot
Comparable measurements from independent market surfaces.
domain observations
Direction-level arXiv matches plus retained GitHub repositories.
arXiv direction matches
Complete counts from 133 monthly direction queries; a paper may match more than one direction.
open-source implementations
Retained from 924 inspected GitHub repositories.
composite supply change
Q1 2025 compared with May–July 2026.
Research and open-source implementation supply
Each source is indexed independently; the Q1 2025 monthly average equals 100.
Which health and science directions are accelerating
Composite change between Q1 2025 and May–July 2026. Sources with fewer than 30 retained items are shown but excluded from that direction's index.
What is changing beneath the headline growth
Structural findings that a single aggregate number would hide.
Autonomous scientific discovery is accelerating fastest
The result reflects relative change inside comparable source cohorts, not the absolute size of the clinical or scientific market.
Clinical diagnostics & imaging remains the largest measured direction
Scale and growth are different signals: the largest body of work is not necessarily the fastest-forming implementation category.
Research and implementation move at different speeds
The equal-weighted index separates scientific attention from visible open-source implementation without treating a thin commercial-platform sample as market demand.